Friday, October 9, 2015
17:00-19:00
Classic and novel approaches for the treatment of atherosclerosis
Chairmen: Dimitrios Mikhailidis (UK), Vedat Sansoy (Turkey)
Established combination therapies for dyslipidaemias – Dimitrios Mikhailidis (UK)
HDL- modifying therapies. Focus on CETP inhibitors – Meral Kayikcioglu (Turkey)
Novel lipid lowering therapies – Alberico Catapano (Italy)
New pharmacologic treatment of obesity – Dimitrios Kiortsis (Greece)
19:30-21:00
Underlying mechanisms of residual cardiovascular risk
Chairmen: Hakan Kultursay (Turkey), Alexandros Tselepis (Greece)
Triglycerides and remnant lipoproteins in cardiovascular risk
Borge Nordestgaard (Denmark)
New insights into the pathophysiological role of Lp(a) – Alexandros Tselepis (Greece)
HDL biology, quantity, quality, and residual risk – Alberico Catapano (Italy)
Non-alcoholic steatohepatitis and cardiovascular risk – Vassilios Athyros (Greece)
Saturday, October 10, 2015
09:00 – 09:30 Lecture
Chairman: Vassilios Nikolaou (Greece)
The role of LDL-cholesterol in cardiovascular risk models stratification – Demosthenes Panagiotakos (Greece)
09:30-11:30
Unresolved issues in statin therapy
Chairmen: Zeki Ongen (Turkey), Moses Elisaf (Greece)
Statins and diabetes mellitus. Which is the evidence? – Moses Elisaf (Greece)
Statins and renal function – Vassilios Athyros (Greece)
Statin-fibrate combination therapy. What is the evidence? – Meral Kayikclioglu (Turkey)
Statin intolerance – Lale Tokgozoglu (Turkey)
12:00-13:30
The future of hypolipidemic therapy
Chairmen: Alberico Catapano (Italy), Nevres Koylan (Turkey)
Molecular biology and physiology of PCSK9 – Gilles Lambert (France)
Hypolipidemic therapy. Unmet needs – Dilek Ural (Turkey)
PCSK9 inhibition: From the bench to the bedside – Evangelos Liberopoulos (Greece)
17:00-18:00
Early Vascular Ageing and atherosclerosis
Chairmen: Vassilios Athyros (Greece), Asterios Karagiannis (Greece)
Early vascular changes in children and adolescents with cardiovascular risk factors – Stella Stabouli (Greece)
Microbiota patterns and risk of glucometabolic disease – Peter Nilsson (Sweden)
The role of statins in arterial stiffness and early vascular ageing – Vassilios Kotsis (Greece)
18:00-19:00
Case presentations. Interactive discussion with participants
Chairmen: Necla Ozer (Turkey), Emmanuel Ganotakis (Greece)
Evangelos Liberopoulos (Greece)
19:00-20:00
Guidelines for the treatment of hyperlipidemias
Presenters: Necla Ozer (Turkey), Christos Pitsavos (Greece)
20:00-21:00
The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
Presenter: Alberico Catapano (Italy)
Sunday, October 11, 2015
08:00-09:30
Short Oral Presentations
Chairmen: Alberico Catapano (Italy), Alexandros Tselepis (Greece)
PHARMACOKINETICS OF SELF NANO EMULSION DRUG DELIVERY SYSTEMS FOR THE ORAL ADMINISTRATION OF ROSUVASTATIN CALCIUM
1Hatice Yesim Karasulu, 2Evren Gundogdu, 3Tugce Turgay, 3Ugur Onsel Turk,
3Sebnem Apaydın, 4Ilgın Yıdırım Simsir, 4Candeger Yilmaz, 3Ercument Karasulu
1Ege University, Faculty of Pharmacy, Department of Pharmaceutical Technology,
Izmir, Turkey;
2Ege University, Faculty of Pharmacy, Radiopharmacy Department, İzmir, Turkey;
3Ege University ARGEFAR Drug Development and Pharmacokinetic Research Center,
Izmir, Turkey;
4Ege University, Medicine Faculty, Endocrinology Department, Izmir, Turkey;
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA (HOMO-FH) IN GREECE: EPIDEMIOLOGICAL DATA FROM 34 PATIENTS
E. Drogari, N. Mavroidis, E. Laios, P. Progias, V. Mollaki
Choremio Research Institute, Metabolic Unit, 1st Department Pediatrics, University of Athens, «Aghia Sofia» Children’s Hospital, Athens, Greece;
SWITCH TO ROSUVASTATIN VERSUS ADDITION OF EZETIMIBE IN PATIENTS RECEIVING ATORVASTATIN: EFFECT ON URINE 8-ISOPROSTANE LEVELS
Eleftherios Klouras, Constantinos Tellis, Fotios Barkas, Evangelos Liberopoulos, Moses Elisaf, Alexandros Tselepis
1Department of Internal Medicine, School of Medicine University of Ioannina,
Ioannina, Greece;
2Atherothrombosis Research Centre / Laboratory of Biochemistry, Department of
Chemistry, University of Ioannina, Ioannina, Greece;
CHOLESTERYL ESTER STORAGE DISEASE IN GREECE: A RARE INBORN ERROR OF METABOLISM PRESENTING WITH DYSLIPIDAIMIA AND LIVER DISEASE
1E. Drogari, 1V. Mollaki, 2H. Christomanou, 3K. Stamatelopoulos, 4N. Manolaki, 1Metabolic and Lipid Clinic, 1st Department of Pediatrics, University of Athens, «Aghia Sofia» Children’s Hospital, Athens Greece;
2Research Center for Lysosomal and Neurodegenerative Disorder, Athens Greece;
3Department of Internal Medicine, University of Athens, «Alexandras» General
Hospital, Athens, Greece;
42nd Department of Pediatrics, NHS, «Aghia Sofia» Children’s Hospital, Athens, Greece;
RISK FACTORS FOR ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE IN CHILDREN AND ADOLESCENTS WITH CHRONIC KIDNEY DISEASE: A SINGLE CENTRE PROSPECTIVE STUDY
1Styliani Drapanioti, 2George Karapostolakis, 3Varvara Askiti, 2Marina Vakaki,
3Andromachi Mitsioni, 3 Maria Mila, 3Constantinos Stefanidis, 1 Anastasia Garoufi
1Lipid Outpatient Unit, 2nd Department of Pediatrics, Athens University, Greece;
2Radiology Department, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece;
3Unit of Pediatric Nephrology, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece;
EVALUATION OF C-REACTIVE PROTEIN ON PROGRESSION OF ATHEROSCLEROSIS ON PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
1Vasiliki Metaxa, 1Ioannis Skoumas, 1Christina Chrysohoou, 1Christos Pitsavos,
2Antigoni Miliou, 1Evaggelos Oikonomou, 1Emmanouil Kampaxis,
1Constantina Masoura, 1Dimitrios Tousoulis
1Lipid Unit, 1st Cardiology Clinic, Hippokrateio Hospital, Greece;
2Molecular and Genetics Department, 1st Cardiology Clinic, Hippokrateio Hospital,
Greece;
CLOPIDOGREL BINDS TO LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) AND INHIBITS THE ENZYME ACTIVITY IN PATIENTS WITH AN ACUTE CORONARY SYNDROME
1Maria Tsoumani, 1Constantinos Tellis, 2Maria Chatziathanasiadou,
2Antigoni Katsikoudi, 2Vassiliki Kontogianni, 2Andreas Tzakos,
1Alexandros Tselepis
1Atherothrombosis Research Center/Laboratory of Biochemistry, Department of
Chemistry, University of Ioannina, Ioannina, Greece;
2Laboratory of Organic Chemistry, Department of Chemistry, University of Ioannina,
Ioannina, Greece;
HYPERLIPIDEMIC NEPHROTIC SYNDROME ASSOCIATED WITH RENAL VEIN THROMBOSIS
1Elif Gram, 1Ferhat Ekinci, 1Mehmet Can Ugur, 1Cihangir Turemis, 3Emrah Akay,
2Mehmet Tanrisev, 1Sezgi Kayikcioglu
1Izmir Tepecik Education and Research Hospital, Department of Internal Medicine, Turkey;
2Izmir Tepecik Education and Research Hospital, Nephrology, Turkey;
3Izmir Tepecik Education and Research Hospital, Radiology, Turkey;
RESISTANCE TO ACTIVATED PROTEIN-C IN PATIENTS WITH EARLY VEIN GRAFT OCCLUSION AFTER CORONARY BYPASS SURGERY
Serdar Payzin, Levent Can, Meral Kayikcioglu, Hakan Kultursay
Ege University Medical School Cardiology Department, Izmir, Turkey;
ANTIPLATELET TREATMENT IN PATIENTS WHO HAVE AN ISCHEMIC STROKE WHILE TAKING ASPIRIN
Konstantinos Tziomalos, Stella Bouziana, Marianna Spanou, Stavroula Kostaki,
Maria Papadopoulou, Vasilios Giampatzis, Maria Tsopozidi, Stella Aggelopoulou,
Christos Savopoulos, Apostolos Hatzitolios
First Propedeutic Department of Internal Medicine, Medical School, Aristotle
University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece;
THE FUNCTIONAL ROLE OF BROWN ADIPOSE TISSUE IN WHOLE-BODY LIPID METABOLISM IN HUMANS
Labros Sidossis Professor, Department of Internal Medicine-Geriatrics, UT Medical Branch at
Galveston, USA, Department of Nutrition and Dietetics, Harokopio University, Athens Greece;